Video Experimental Relacionado
Updated: Jul 19, 2026
13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Tratamiento del sangrado traumático con el factor VIIa recombinante
Lancet (London, England)
|December 10, 1999
Resumen
El factor VIIa recombinante trató eficazmente la coagulopatía severa y el sangrado potencialmente mortal después del fracaso quirúrgico. Esta administración de factor VIIa recombinante corrigió rápidamente la coagulación y detuvo la hemorragia.
Área de la Ciencia:
- Manejo de traumas y hemorragias.
- Ciencia de la coagulación Ciencia de la coagulación.
Sus antecedentes:
- La coagulopatía grave plantea un desafío significativo en el manejo de la hemorragia potencialmente mortal.
- Las intervenciones quirúrgicas estándar pueden ser insuficientes en casos de trastornos hemorrágicos complejos.
Objetivo del estudio:
- Evaluar la eficacia del factor VIIa recombinante (rFVIIa) en el tratamiento de la hemorragia potencialmente mortal debido a la coagulopatía grave.
- Evaluar el papel de rFVIIa como terapia complementaria cuando la intervención quirúrgica es insuficiente.
Principales métodos:
- Informe de caso detallando el curso clínico de un paciente con coagulopatía grave y sangrado incontrolado.
- Administración de rFVIIa después de una hemostasis quirúrgica fallida.
Principales resultados:
- La intervención quirúrgica no logró lograr la hemostasis.
- La administración inmediata de rFVIIa corrigió rápidamente la coagulopatía.
- La hemorragia fue controlada de manera efectiva después de la administración de rFVIIa.
Conclusiones:
- El factor VIIa recombinante es un tratamiento altamente efectivo para la hemorragia grave asociada a la coagulopatía cuando fallan los métodos quirúrgicos estándar.
- rFVIIa puede restaurar rápidamente la hemostasis en escenarios críticos de sangrado.
Videos de Conceptos Relacionados
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...